1. Home
  2. BCAB vs NISN Comparison

BCAB vs NISN Comparison

Compare BCAB & NISN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • NISN
  • Stock Information
  • Founded
  • BCAB 2007
  • NISN 2005
  • Country
  • BCAB United States
  • NISN China
  • Employees
  • BCAB N/A
  • NISN N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • NISN Metal Fabrications
  • Sector
  • BCAB Health Care
  • NISN Industrials
  • Exchange
  • BCAB Nasdaq
  • NISN Nasdaq
  • Market Cap
  • BCAB 22.3M
  • NISN 23.5M
  • IPO Year
  • BCAB 2020
  • NISN 2016
  • Fundamental
  • Price
  • BCAB $0.41
  • NISN $3.36
  • Analyst Decision
  • BCAB Buy
  • NISN
  • Analyst Count
  • BCAB 2
  • NISN 0
  • Target Price
  • BCAB $1.00
  • NISN N/A
  • AVG Volume (30 Days)
  • BCAB 561.7K
  • NISN 57.7K
  • Earning Date
  • BCAB 08-07-2025
  • NISN 04-29-2025
  • Dividend Yield
  • BCAB N/A
  • NISN N/A
  • EPS Growth
  • BCAB N/A
  • NISN N/A
  • EPS
  • BCAB N/A
  • NISN 1.43
  • Revenue
  • BCAB $11,000,000.00
  • NISN $340,219,546.00
  • Revenue This Year
  • BCAB N/A
  • NISN N/A
  • Revenue Next Year
  • BCAB N/A
  • NISN N/A
  • P/E Ratio
  • BCAB N/A
  • NISN $14.76
  • Revenue Growth
  • BCAB N/A
  • NISN 8.05
  • 52 Week Low
  • BCAB $0.24
  • NISN $3.14
  • 52 Week High
  • BCAB $2.53
  • NISN $22.55
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 44.32
  • NISN 33.74
  • Support Level
  • BCAB $0.38
  • NISN $3.40
  • Resistance Level
  • BCAB $0.46
  • NISN $3.97
  • Average True Range (ATR)
  • BCAB 0.06
  • NISN 0.41
  • MACD
  • BCAB -0.01
  • NISN -0.05
  • Stochastic Oscillator
  • BCAB 9.36
  • NISN 4.08

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About NISN NiSun International Enterprise Development Group Co. Ltd.

NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.

Share on Social Networks: